Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 18,702 | 12,785 | 14,533 | 3,288 | 3,428 |
| Gross Profit | 18,702 | 12,785 | 14,533 | 3,288 | 3,428 |
| Operating Expenses | 31,871 | 25,567 | 22,616 | 17,480 | 14,675 |
| Operating Income | -13,169 | -12,782 | -8,083 | -14,192 | -11,247 |
| Interest Expense | 24 | 28 | 28 | 25 | 34 |
| Other Income | 118 | 124 | 125 | 228 | 349 |
| Pre-tax Income | -13,075 | -12,686 | -7,986 | -13,989 | -10,932 |
| Net Income Continuous | -13,075 | -12,686 | -7,986 | -13,989 | -10,932 |
| Net Income | $-13,075 | $-12,686 | $-7,986 | $-13,989 | $-10,932 |
| EPS Basic Total Ops | -0.29 | 14.45 | -0.39 | -6.98 | -10.23 |
| EPS Basic Continuous Ops | -0.29 | 10.34 | -0.39 | -6.98 | -5.60 |
| EPS Diluted Total Ops | -0.29 | 14.45 | -0.39 | -6.98 | -10.23 |
| EPS Diluted Continuous Ops | -0.29 | 10.34 | -0.39 | -6.98 | -5.60 |
| EBITDA(a) | $-11,405 | $-10,714 | $-7,593 | $-13,803 | $-10,860 |